BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ito I, Fukazawa J, Yoshida M. Post-translational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils. J Biol Chem. 2007;282:16336-16344. [PMID: 17403684 DOI: 10.1074/jbc.m608467200] [Cited by in Crossref: 137] [Cited by in F6Publishing: 83] [Article Influence: 9.1] [Reference Citation Analysis]
Number Citing Articles
1 Lu B, Wang C, Wang M, Li W, Chen F, Tracey KJ, Wang H. Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review. Expert Rev Clin Immunol 2014;10:713-27. [PMID: 24746113 DOI: 10.1586/1744666X.2014.909730] [Cited by in Crossref: 82] [Cited by in F6Publishing: 53] [Article Influence: 10.3] [Reference Citation Analysis]
2 Xia Q, Xu J, Chen H, Gao Y, Gong F, Hu L, Yang L. Association between an elevated level of HMGB1 and non-small-cell lung cancer: a meta-analysis and literature review. Onco Targets Ther 2016;9:3917-23. [PMID: 27418836 DOI: 10.2147/OTT.S104409] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
3 Sekiguchi F, Kawabata A. Role of HMGB1 in Chemotherapy-Induced Peripheral Neuropathy. Int J Mol Sci 2020;22:E367. [PMID: 33396481 DOI: 10.3390/ijms22010367] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Ge WS, Wu JX, Fan JG, Wang YJ, Chen YW. Inhibition of high-mobility group box 1 expression by siRNA in rat hepatic stellate cells. World J Gastroenterol 2011; 17(36): 4090-4098 [PMID: 22039322 DOI: 10.3748/wjg.v17.i36.4090] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
5 Liu A, Dirsch O, Fang H, Sun J, Jin H, Dong W, Dahmen U. HMGB1 in ischemic and non-ischemic liver after selective warm ischemia/reperfusion in rat. Histochem Cell Biol 2011;135:443-52. [DOI: 10.1007/s00418-011-0802-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
6 Yang K, Fan M, Wang X, Xu J, Wang Y, Tu F, Gill PS, Ha T, Liu L, Williams DL, Li C. Lactate promotes macrophage HMGB1 lactylation, acetylation, and exosomal release in polymicrobial sepsis. Cell Death Differ 2021. [PMID: 34363018 DOI: 10.1038/s41418-021-00841-9] [Reference Citation Analysis]
7 Gaskell H, Ge X, Nieto N. High-Mobility Group Box-1 and Liver Disease. Hepatol Commun 2018;2:1005-20. [PMID: 30202816 DOI: 10.1002/hep4.1223] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
8 Yuan S, Liu Z, Xu Z, Liu J, Zhang J. High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies. J Hematol Oncol 2020;13:91. [PMID: 32660524 DOI: 10.1186/s13045-020-00920-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
9 Stevens NE, Nash CH, Fraser CK, Kuchel TR, Maiden MJ, Chapman MJ, Diener KR, Hayball JD. High mobility group box protein 1 neutralization therapy in ovine bacteremia: Lessons learned from an ovine septic shock model incorporating intensive care support. Exp Ther Med 2019;18:3271-80. [PMID: 31602200 DOI: 10.3892/etm.2019.7961] [Reference Citation Analysis]
10 Liu A, Fang H, Dirsch O, Jin H, Dahmen U. Oxidation of HMGB1 causes attenuation of its pro-inflammatory activity and occurs during liver ischemia and reperfusion. PLoS One 2012;7:e35379. [PMID: 22514737 DOI: 10.1371/journal.pone.0035379] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
11 Ding J, Cui X, Liu Q. Emerging role of HMGB1 in lung diseases: Friend or foe. J Cell Mol Med. 2017;21:1046-1057. [PMID: 28039939 DOI: 10.1111/jcmm.13048] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
12 Mauracher LM, Buchtele N, Schörgenhofer C, Weiser C, Herkner H, Merrelaar A, Spiel AO, Hell L, Ay C, Pabinger I, Jilma B, Schwameis M. Increased Citrullinated Histone H3 Levels in the Early Post-Resuscitative Period Are Associated with Poor Neurologic Function in Cardiac Arrest Survivors-A Prospective Observational Study. J Clin Med 2019;8:E1568. [PMID: 31581493 DOI: 10.3390/jcm8101568] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Davies JE, Apta BHR, Harper MT. Cross-reactivity of anti-HMGB1 antibodies for HMGB2. J Immunol Methods 2018;456:72-6. [PMID: 29453955 DOI: 10.1016/j.jim.2018.02.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Bertheloot D, Latz E. HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins. Cell Mol Immunol 2017;14:43-64. [PMID: 27569562 DOI: 10.1038/cmi.2016.34] [Cited by in Crossref: 203] [Cited by in F6Publishing: 204] [Article Influence: 33.8] [Reference Citation Analysis]
15 Adamo A, Frusteri C, Pallotta MT, Pirali T, Sartoris S, Ugel S. Moonlighting Proteins Are Important Players in Cancer Immunology. Front Immunol 2020;11:613069. [PMID: 33584695 DOI: 10.3389/fimmu.2020.613069] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Hwang JS, Kang ES, Han SG, Lim DS, Paek KS, Lee CH, Seo HG. Formononetin inhibits lipopolysaccharide-induced release of high mobility group box 1 by upregulating SIRT1 in a PPARδ-dependent manner. PeerJ 2018;6:e4208. [PMID: 29312829 DOI: 10.7717/peerj.4208] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
17 Thapar R. Structure-specific nucleic acid recognition by L-motifs and their diverse roles in expression and regulation of the genome. Biochim Biophys Acta 2015;1849:677-87. [PMID: 25748361 DOI: 10.1016/j.bbagrm.2015.02.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
18 Malarkey CS, Churchill ME. The high mobility group box: The ultimate utility player of a cell. Trends Biochem Sci. 2012;37:553-562. [PMID: 23153957 DOI: 10.1016/j.tibs.2012.09.003] [Cited by in Crossref: 114] [Cited by in F6Publishing: 106] [Article Influence: 11.4] [Reference Citation Analysis]
19 Hirsiger S, Simmen HP, Werner CM, Wanner GA, Rittirsch D. Danger signals activating the immune response after trauma. Mediators Inflamm. 2012;2012:189-194. [PMID: 22778496 DOI: 10.1155/2012/315941] [Cited by in Crossref: 132] [Cited by in F6Publishing: 126] [Article Influence: 13.2] [Reference Citation Analysis]
20 Nativel B, Marimoutou M, Thon-Hon VG, Gunasekaran MK, Andries J, Stanislas G, Planesse C, Da Silva CR, Césari M, Iwema T, Gasque P, Viranaicken W. Soluble HMGB1 is a novel adipokine stimulating IL-6 secretion through RAGE receptor in SW872 preadipocyte cell line: contribution to chronic inflammation in fat tissue. PLoS One 2013;8:e76039. [PMID: 24073286 DOI: 10.1371/journal.pone.0076039] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 6.1] [Reference Citation Analysis]
21 Lee W, Ku SK, Park EJ, Na DH, Kim KM, Bae JS. Exendin-4 inhibits HMGB1-induced inflammatory responses in HUVECs and in murine polymicrobial sepsis. Inflammation 2014;37:1876-88. [PMID: 24826914 DOI: 10.1007/s10753-014-9919-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
22 Kuroda N, Inoue K, Ikeda T, Hara Y, Wake K, Sato T. Apoptotic response through a high mobility box 1 protein-dependent mechanism in LPS/GalN-induced mouse liver failure and glycyrrhizin-mediated inhibition. PLoS One 2014;9:e92884. [PMID: 24690901 DOI: 10.1371/journal.pone.0092884] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
23 de Abreu da Silva IC, Carneiro VC, Maciel Rde M, da Costa RF, Furtado DR, de Oliveira FM, da Silva-Neto MA, Rumjanek FD, Fantappié MR. CK2 phosphorylation of Schistosoma mansoni HMGB1 protein regulates its cellular traffic and secretion but not its DNA transactions. PLoS One 2011;6:e23572. [PMID: 21887276 DOI: 10.1371/journal.pone.0023572] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
24 Zhang Q, Wang Y. High mobility group proteins and their post-translational modifications. Biochim Biophys Acta 2008;1784:1159-66. [PMID: 18513496 DOI: 10.1016/j.bbapap.2008.04.028] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 4.0] [Reference Citation Analysis]
25 Liu YJ, Li W, Chang F, Liu JN, Lin JX, Chen DX. MicroRNA-505 is downregulated in human osteosarcoma and regulates cell proliferation, migration and invasion. Oncol Rep 2018;39:491-500. [PMID: 29251324 DOI: 10.3892/or.2017.6142] [Cited by in Crossref: 6] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
26 Lanouette S, Mongeon V, Figeys D, Couture JF. The functional diversity of protein lysine methylation. Mol Syst Biol 2014;10:724. [PMID: 24714364 DOI: 10.1002/msb.134974] [Cited by in Crossref: 154] [Cited by in F6Publishing: 141] [Article Influence: 19.3] [Reference Citation Analysis]
27 Hou C, Zhao H, Liu L, Li W, Zhou X, Lv Y, Shen X, Liang Z, Cai S, Zou F. High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls. Mol Med 2011;17:807-15. [PMID: 21380479 DOI: 10.2119/molmed.2010.00173] [Cited by in Crossref: 85] [Cited by in F6Publishing: 90] [Article Influence: 7.7] [Reference Citation Analysis]
28 Todorova J, Pasheva E. High mobility group B1 protein interacts with its receptor RAGE in tumor cells but not in normal tissues. Oncol Lett 2012;3:214-8. [PMID: 22740883 DOI: 10.3892/ol.2011.459] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
29 Tang Y, Zhao X, Antoine D, Xiao X, Wang H, Andersson U, Billiar TR, Tracey KJ, Lu B. Regulation of Posttranslational Modifications of HMGB1 During Immune Responses. Antioxid Redox Signal 2016;24:620-34. [PMID: 26715031 DOI: 10.1089/ars.2015.6409] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 9.8] [Reference Citation Analysis]
30 Hu Z, Wang X, Gong L, Wu G, Peng X, Tang X. Role of high-mobility group box 1 protein in inflammatory bowel disease. Inflamm Res 2015;64:557-63. [PMID: 26077468 DOI: 10.1007/s00011-015-0841-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
31 Rabadi MM, Xavier S, Vasko R, Kaur K, Goligorksy MS, Ratliff BB. High-mobility group box 1 is a novel deacetylation target of Sirtuin1. Kidney Int. 2015;87:95-108. [PMID: 24940804 DOI: 10.1038/ki.2014.217] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 7.6] [Reference Citation Analysis]
32 Weng L, Guo L, Vachani A, Mesaros C, Blair IA. Quantification of Serum High Mobility Group Box 1 by Liquid Chromatography/High-Resolution Mass Spectrometry: Implications for Its Role in Immunity, Inflammation, and Cancer. Anal Chem 2018;90:7552-60. [PMID: 29791130 DOI: 10.1021/acs.analchem.8b01175] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
33 Kwak MS, Kim HS, Lee B, Kim YH, Son M, Shin JS. Immunological Significance of HMGB1 Post-Translational Modification and Redox Biology. Front Immunol 2020;11:1189. [PMID: 32587593 DOI: 10.3389/fimmu.2020.01189] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
34 Cursio R, Colosetti P, Gugenheim J. Autophagy and liver ischemia-reperfusion injury. Biomed Res Int. 2015;2015:417590. [PMID: 25861623 DOI: 10.1155/2015/417590] [Cited by in Crossref: 59] [Cited by in F6Publishing: 67] [Article Influence: 8.4] [Reference Citation Analysis]
35 Liu A, Jin H, Dirsch O, Deng M, Huang H, Bröcker-Preuss M, Dahmen U. Release of danger signals during ischemic storage of the liver: a potential marker of organ damage? Mediators Inflamm 2010;2010:436145. [PMID: 21197406 DOI: 10.1155/2010/436145] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
36 Gaillard C, Borde C, Gozlan J, Maréchal V, Strauss F. A high-sensitivity method for detection and measurement of HMGB1 protein concentration by high-affinity binding to DNA hemicatenanes. PLoS One 2008;3:e2855. [PMID: 18682735 DOI: 10.1371/journal.pone.0002855] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
37 Cantoni C, Huergo-Zapico L, Parodi M, Pedrazzi M, Mingari MC, Moretta A, Sparatore B, Gonzalez S, Olive D, Bottino C, Castriconi R, Vitale M. NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy? J Immunol Res 2016;2016:4684268. [PMID: 27294158 DOI: 10.1155/2016/4684268] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 8.2] [Reference Citation Analysis]
38 Sitapara RA, Antoine DJ, Sharma L, Patel VS, Ashby CR Jr, Gorasiya S, Yang H, Zur M, Mantell LL. The α7 nicotinic acetylcholine receptor agonist GTS-21 improves bacterial clearance in mice by restoring hyperoxia-compromised macrophage function. Mol Med 2014;20:238-47. [PMID: 24664237 DOI: 10.2119/molmed.2013.00086] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
39 Splichal I, Donovan SM, Jenistova V, Splichalova I, Salmonova H, Vlkova E, Neuzil Bunesova V, Sinkora M, Killer J, Skrivanova E, Splichalova A. High Mobility Group Box 1 and TLR4 Signaling Pathway in Gnotobiotic Piglets Colonized/Infected with L. amylovorus, L. mucosae, E. coli Nissle 1917 and S. Typhimurium. Int J Mol Sci 2019;20:E6294. [PMID: 31847111 DOI: 10.3390/ijms20246294] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
40 Chikhirzhina E, Starkova T, Beljajev A, Polyanichko A, Tomilin A. Functional Diversity of Non-Histone Chromosomal Protein HmgB1. Int J Mol Sci 2020;21:E7948. [PMID: 33114717 DOI: 10.3390/ijms21217948] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 Li Y, Ye X, Liu J, Zha J, Pei L. Evaluation of EML4-ALK fusion proteins in non-small cell lung cancer using small molecule inhibitors. Neoplasia 2011;13:1-11. [PMID: 21245935 DOI: 10.1593/neo.101120] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]
42 Yoo H, Ku SK, Han MS, Kim KM, Bae JS. Anti-septic effects of fisetin in vitro and in vivo. Inflammation 2014;37:1560-74. [PMID: 24706001 DOI: 10.1007/s10753-014-9883-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
43 Deng M, Scott MJ, Fan J, Billiar TR. Location is the key to function: HMGB1 in sepsis and trauma-induced inflammation. J Leukoc Biol 2019;106:161-9. [PMID: 30946496 DOI: 10.1002/JLB.3MIR1218-497R] [Cited by in Crossref: 18] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
44 Hernández-Pando R, Barrios-Payán J, Mata-Espinosa D, Marquina-Castillo B, Hernández-Ramírez D, Bottasso OA, Bini EI. The Role of High Mobility Group Box 1 Protein (HMGB1) in the Immunopathology of Experimental Pulmonary Tuberculosis. PLoS One 2015;10:e0133200. [PMID: 26201072 DOI: 10.1371/journal.pone.0133200] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
45 Wang FP, Li L, Li J, Wang JY, Wang LY, Jiang W. High mobility group box-1 promotes the proliferation and migration of hepatic stellate cells via TLR4-dependent signal pathways of PI3K/Akt and JNK. PLoS One. 2013;8:e64373. [PMID: 23696886 DOI: 10.1371/journal.pone.0064373] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 7.2] [Reference Citation Analysis]
46 Kwak MS, Lim M, Lee YJ, Lee HS, Kim YH, Youn JH, Choi JE, Shin JS. HMGB1 Binds to Lipoteichoic Acid and Enhances TNF-α and IL-6 Production through HMGB1-Mediated Transfer of Lipoteichoic Acid to CD14 and TLR2. J Innate Immun 2015;7:405-16. [PMID: 25660311 DOI: 10.1159/000369972] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
47 He SJ, Cheng J, Feng X, Yu Y, Tian L, Huang Q. The dual role and therapeutic potential of high-mobility group box 1 in cancer. Oncotarget 2017;8:64534-50. [PMID: 28969092 DOI: 10.18632/oncotarget.17885] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 11.8] [Reference Citation Analysis]
48 Liu P, Zhao L, Loos F, Iribarren K, Lachkar S, Zhou H, Gomes-da-Silva LC, Chen G, Bezu L, Boncompain G, Perez F, Zitvogel L, Kepp O, Kroemer G. Identification of pharmacological agents that induce HMGB1 release. Sci Rep 2017;7:14915. [PMID: 29097772 DOI: 10.1038/s41598-017-14848-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
49 Ying S, Xiao X, Chen T, Lou J. PPAR Ligands Function as Suppressors That Target Biological Actions of HMGB1. PPAR Res 2016;2016:2612743. [PMID: 27563308 DOI: 10.1155/2016/2612743] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
50 Harris HE, Andersson U, Pisetsky DS. HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease. Nat Rev Rheumatol. 2012;8:195-202. [PMID: 22293756 DOI: 10.1038/nrrheum.2011.222] [Cited by in Crossref: 427] [Cited by in F6Publishing: 425] [Article Influence: 42.7] [Reference Citation Analysis]
51 Raucci A, Di Maggio S, Scavello F, D'Ambrosio A, Bianchi ME, Capogrossi MC. The Janus face of HMGB1 in heart disease: a necessary update. Cell Mol Life Sci. 2019;76:211-229. [PMID: 30306212 DOI: 10.1007/s00018-018-2930-9] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 9.3] [Reference Citation Analysis]
52 Reeves R. Nuclear functions of the HMG proteins. Biochim Biophys Acta 2010;1799:3-14. [PMID: 19748605 DOI: 10.1016/j.bbagrm.2009.09.001] [Cited by in Crossref: 160] [Cited by in F6Publishing: 145] [Article Influence: 12.3] [Reference Citation Analysis]
53 Pilzweger C, Holdenrieder S. Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune Diseases. Diagnostics (Basel) 2015;5:219-53. [PMID: 26854151 DOI: 10.3390/diagnostics5020219] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
54 Pisetsky D. Cell death in the pathogenesis of immune-mediated diseases: the role of HMGB1 and DAMP-PAMP complexes. Swiss Med Wkly 2011;141:w13256. [PMID: 21877298 DOI: 10.4414/smw.2011.13256] [Cited by in Crossref: 6] [Cited by in F6Publishing: 26] [Article Influence: 0.5] [Reference Citation Analysis]
55 Xu H, Wandersee NJ, Guo Y, Jones DW, Holzhauer SL, Hanson MS, Machogu E, Brousseau DC, Hogg N, Densmore JC, Kaul S, Hillery CA, Pritchard KA Jr. Sickle cell disease increases high mobility group box 1: a novel mechanism of inflammation. Blood 2014;124:3978-81. [PMID: 25339362 DOI: 10.1182/blood-2014-04-560813] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.5] [Reference Citation Analysis]
56 Fujioka M, Nakano T, Hayakawa K, Irie K, Akitake Y, Sakamoto Y, Mishima K, Muroi C, Yonekawa Y, Banno F, Kokame K, Miyata T, Nishio K, Okuchi K, Iwasaki K, Fujiwara M, Siesjö BK. ADAMTS13 gene deletion enhances plasma high-mobility group box1 elevation and neuroinflammation in brain ischemia-reperfusion injury. Neurol Sci 2012;33:1107-15. [PMID: 22212812 DOI: 10.1007/s10072-011-0913-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
57 Gougeon ML, Melki MT, Saïdi H. HMGB1, an alarmin promoting HIV dissemination and latency in dendritic cells. Cell Death Differ 2012;19:96-106. [PMID: 22033335 DOI: 10.1038/cdd.2011.134] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
58 Gangemi S, Casciaro M, Trapani G, Quartuccio S, Navarra M, Pioggia G, Imbalzano E. Association between HMGB1 and COPD: A Systematic Review. Mediators Inflamm 2015;2015:164913. [PMID: 26798204 DOI: 10.1155/2015/164913] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
59 Lee SY, Ju MK, Jeon HM, Jeong EK, Lee YJ, Kim CH, Park HG, Han SI, Kang HS. Regulation of Tumor Progression by Programmed Necrosis. Oxid Med Cell Longev 2018;2018:3537471. [PMID: 29636841 DOI: 10.1155/2018/3537471] [Cited by in Crossref: 49] [Cited by in F6Publishing: 55] [Article Influence: 12.3] [Reference Citation Analysis]
60 Pisetsky DS. The translocation of nuclear molecules during inflammation and cell death. Antioxid Redox Signal 2014;20:1117-25. [PMID: 23373769 DOI: 10.1089/ars.2012.5143] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
61 Ge Y, Huang M, Yao YM. The Effect and Regulatory Mechanism of High Mobility Group Box-1 Protein on Immune Cells in Inflammatory Diseases. Cells 2021;10:1044. [PMID: 33925132 DOI: 10.3390/cells10051044] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
62 Pisetsky DS, Erlandsson-Harris H, Andersson U. High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease. Arthritis Res Ther. 2008;10:209. [PMID: 18598385 DOI: 10.1186/ar2440] [Cited by in Crossref: 134] [Cited by in F6Publishing: 132] [Article Influence: 9.6] [Reference Citation Analysis]
63 Di Candia L, Gomez E, Venereau E, Chachi L, Kaur D, Bianchi ME, Challiss RAJ, Brightling CE, Saunders RM. HMGB1 is upregulated in the airways in asthma and potentiates airway smooth muscle contraction via TLR4. J Allergy Clin Immunol 2017;140:584-587.e8. [PMID: 28259445 DOI: 10.1016/j.jaci.2016.11.049] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
64 Wang D, Liu K, Fukuyasu Y, Teshigawara K, Fu L, Wake H, Ohtsuka A, Nishibori M. HMGB1 Translocation in Neurons after Ischemic Insult: Subcellular Localization in Mitochondria and Peroxisomes. Cells 2020;9:E643. [PMID: 32155899 DOI: 10.3390/cells9030643] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
65 Tang D, Kang R, Zeh HJ, Lotze MT. High-mobility group box 1 and cancer. Biochim Biophys Acta. 2010;1799:131-140. [PMID: 20123075 DOI: 10.1016/j.bbagrm.2009.11.014] [Cited by in Crossref: 334] [Cited by in F6Publishing: 345] [Article Influence: 27.8] [Reference Citation Analysis]
66 Gill R, Tsung A, Billiar T. Linking oxidative stress to inflammation: Toll-like receptors. Free Radic Biol Med. 2010;48:1121-1132. [PMID: 20083193 DOI: 10.1016/j.freeradbiomed.2010.01.006] [Cited by in Crossref: 329] [Cited by in F6Publishing: 326] [Article Influence: 27.4] [Reference Citation Analysis]
67 Zeng W, Shan W, Gao L, Gao D, Hu Y, Wang G, Zhang N, Li Z, Tian X, Xu W. Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease. Sci Rep. 2015;5:16013. [PMID: 26525891 DOI: 10.1038/srep16013] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 8.6] [Reference Citation Analysis]
68 Hwang JS, Lee WJ, Kang ES, Ham SA, Yoo T, Paek KS, Lim DS, Do JT, Seo HG. Ligand-activated peroxisome proliferator-activated receptor-δ and -γ inhibit lipopolysaccharide-primed release of high mobility group box 1 through upregulation of SIRT1. Cell Death Dis 2014;5:e1432. [PMID: 25275593 DOI: 10.1038/cddis.2014.406] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 4.5] [Reference Citation Analysis]
69 Zhang Q, Wang Y. HMG modifications and nuclear function. Biochim Biophys Acta 2010;1799:28-36. [PMID: 20123066 DOI: 10.1016/j.bbagrm.2009.11.009] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 3.9] [Reference Citation Analysis]
70 Li Y, Xie J, Li X, Fang J. Poly (ADP-ribosylation) of HMGB1 facilitates its acetylation and promotes HMGB1 translocation-associated chemotherapy-induced autophagy in leukaemia cells. Oncol Lett 2020;19:368-78. [PMID: 31897149 DOI: 10.3892/ol.2019.11116] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
71 Roychowdhury T, Chattopadhyay S. Chemical Decorations of "MARs" Residents in Orchestrating Eukaryotic Gene Regulation. Front Cell Dev Biol 2020;8:602994. [PMID: 33409278 DOI: 10.3389/fcell.2020.602994] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
72 Gerlitz G, Hock R, Ueda T, Bustin M. The dynamics of HMG protein-chromatin interactions in living cells. Biochem Cell Biol 2009;87:127-37. [PMID: 19234529 DOI: 10.1139/O08-110] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 4.1] [Reference Citation Analysis]
73 Agalave NM, Svensson CI. Extracellular high-mobility group box 1 protein (HMGB1) as a mediator of persistent pain. Mol Med 2015;20:569-78. [PMID: 25222915 DOI: 10.2119/molmed.2014.00176] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 7.3] [Reference Citation Analysis]
74 Ramos-Sánchez JM, Triozzi PM, Moreno-Cortés A, Conde D, Perales M, Allona I. Real-time monitoring of PtaHMGB activity in poplar transactivation assays. Plant Methods 2017;13:50. [PMID: 28638438 DOI: 10.1186/s13007-017-0199-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
75 Lundbäck P, Stridh P, Klevenvall L, Jenkins RE, Fischer M, Sundberg E, Andersson U, Antoine DJ, Harris HE. Characterization of the Inflammatory Properties of Actively Released HMGB1 in Juvenile Idiopathic Arthritis. Antioxid Redox Signal 2016;24:605-19. [PMID: 25532033 DOI: 10.1089/ars.2014.6039] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
76 Youn JH, Kwak MS, Wu J, Kim ES, Ji Y, Min HJ, Yoo JH, Choi JE, Cho HS, Shin JS. Identification of lipopolysaccharide-binding peptide regions within HMGB1 and their effects on subclinical endotoxemia in a mouse model. Eur J Immunol 2011;41:2753-62. [PMID: 21660935 DOI: 10.1002/eji.201141391] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 4.7] [Reference Citation Analysis]
77 Norbury KC, Moyer MP. Effect of Negative Pressure Therapy on the Inflammatory Response of the Intestinal Microenvironment in a Porcine Septic Model. Mediators Inflamm 2015;2015:419841. [PMID: 26294849 DOI: 10.1155/2015/419841] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
78 Splichal I, Splichalova A. High Mobility Group Box 1 in Pig Amniotic Membrane Experimentally Infected with E. coli O55. Biomolecules 2021;11:1146. [PMID: 34439812 DOI: 10.3390/biom11081146] [Reference Citation Analysis]
79 Lee SA, Kwak MS, Kim S, Shin JS. The role of high mobility group box 1 in innate immunity. Yonsei Med J 2014;55:1165-76. [PMID: 25048472 DOI: 10.3349/ymj.2014.55.5.1165] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 8.6] [Reference Citation Analysis]
80 Ghosh SS, Ghosh S. HMGB1 (High-Mobility Group Box-1): A Common Link Determining the Consequences of Tissue Injury, Sterile/Microbial and Low-Grade Chronic Inflammation. Arterioscler Thromb Vasc Biol 2020;40:2561-3. [PMID: 33085519 DOI: 10.1161/ATVBAHA.120.315189] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
81 Kappes F, Fahrer J, Khodadoust MS, Tabbert A, Strasser C, Mor-Vaknin N, Moreno-Villanueva M, Bürkle A, Markovitz DM, Ferrando-May E. DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress. Mol Cell Biol 2008;28:3245-57. [PMID: 18332104 DOI: 10.1128/MCB.01921-07] [Cited by in Crossref: 69] [Cited by in F6Publishing: 51] [Article Influence: 4.9] [Reference Citation Analysis]
82 Wang Y, Zhong J, Zhang X, Liu Z, Yang Y, Gong Q, Ren B. The Role of HMGB1 in the Pathogenesis of Type 2 Diabetes. J Diabetes Res 2016;2016:2543268. [PMID: 28101517 DOI: 10.1155/2016/2543268] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 6.0] [Reference Citation Analysis]
83 Kong Q, Li Y, Liang Q, Xie J, Li X, Fang J. SIRT6-PARP1 is involved in HMGB1 polyADP-ribosylation and acetylation and promotes chemotherapy-induced autophagy in leukemia. Cancer Biol Ther 2020;21:320-31. [PMID: 31928132 DOI: 10.1080/15384047.2019.1702397] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]